BioBridge Global continues history of innovation with umbilical cord collection and processing under cGMP standards for further manufacture
November 18, 2021 09:00 ET
|
BioBridge Global
San Antonio, Texas, Nov. 18, 2021 (GLOBE NEWSWIRE) -- BioBridge Global is committed to supporting advanced therapies through the development and delivery of services from source material collection,...
Inspection Machines Market Size ($1,172.99Mn by 2028) Lead by Vision Inspection Systems (5.3% CAGR) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com
November 03, 2021 10:25 ET
|
The Insight Partners
New York, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Inspection Machine Market: Key InsightsAccording to our new research study on Inspection Machines Market Size, Share, Revenue, Forecast to 2028 - Covid-19...
Global Flexible Manufacturing Systems in the Pharmaceutical Industry Market (2021 to 2026) - Rising Opportunities with Industry 4.0 and Pharma 4.0
October 26, 2021 07:23 ET
|
Research and Markets
Dublin, Oct. 26, 2021 (GLOBE NEWSWIRE) -- The "Global Market for Flexible Manufacturing Systems in the Pharmaceutical Industry" report has been added to ResearchAndMarkets.com's offering. This...
Josh Wilhelm Joins PetVivo Holdings, Inc. as the Director of Manufacturing
September 08, 2021 08:00 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Sept. 08, 2021 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV) (the "Company") an emerging biomedical device company focused on the commercialization of innovative...
Psychedelic Joint Venture Between Mycotopia Therapies and Natural MedTech Brings Research and Drug Development to Test Active Ingredient In Psychedelics
March 22, 2021 07:00 ET
|
20/20 Global, Inc.
MIAMI, March 22, 2021 (GLOBE NEWSWIRE) -- 20/20 Global, Inc. dba Mycotopia Therapies, (OTC Pink: TWGL) (the “Company”), a company focused on psychedelic therapies, announced today it has formed...
Cytovance Biologics now offering Licensing for Plasmid DNA Manufacturing
March 08, 2021 03:00 ET
|
Cytovance Biologics
OKLAHOMA CITY, March 08, 2021 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian, microbial biologics and...
Cytovance Biologics offers Nature Technology Corporation’s proprietary HyperGRO™ manufacturing platform for plasmid DNA CGMP manufacturing
November 30, 2020 03:00 ET
|
Cytovance Biologics
OKLAHOMA CITY, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian, microbial biologics and...
Provectus Biopharmaceuticals Highlights Stage IV M1c Patient Outcome from Combination Therapy Trial of PV-10® and KEYTRUDA® for Checkpoint-Naïve Advanced Cutaneous Melanoma at ESMO Virtual Congress 2020
September 21, 2020 12:45 ET
|
Provectus Biopharmaceuticals Inc.
Near-resolution of tumor burden, including extensive visceral hepatic diseaseExpanded data set of trial subject provided KNOXVILLE, TN, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT)...
Global CDMO Industry Insights Report 2019-2025: Market Size Breakdown by Type of Service, Type of Molecule, End Use and Region
September 02, 2020 05:19 ET
|
Research and Markets
Dublin, Sept. 02, 2020 (GLOBE NEWSWIRE) -- The "Global Market Opportunities and Competitive Landscape for CDMO" report has been added to ResearchAndMarkets.com's offering. This report provides an...
Provectus Biopharmaceuticals Expands Sponsored Research Collaboration with University of Calgary (Canada) to Investigate Oral Administration of Rose Bengal Disodium for Cancer Treatment
August 13, 2020 08:00 ET
|
Provectus Biopharmaceuticals Inc.
University of Calgary researchers have successfully demonstrated initial, in vivo proof-of-concept, oral rose bengal disodium treatment for blood cancerResearchers will now investigate oral treatment...